Investigational Drug Information for LY3214996
✉ Email this page to a colleague
What is the development status for investigational drug LY3214996?
LY3214996 is an investigational drug.
There have been 10 clinical trials for LY3214996.
The most recent clinical trial was a Phase 1 trial, which was initiated on May 27th 2020.
The most common disease conditions in clinical trials are Adenocarcinoma, Pancreatic Neoplasms, and Colorectal Neoplasms. The leading clinical trial sponsors are Eli Lilly and Company, Dana-Farber Cancer Institute, and Lustgarten Foundation.
There are two US patents protecting this investigational drug and forty-two international patents.
Summary for LY3214996
| US Patents | 2 |
| International Patents | 42 |
| US Patent Applications | 12 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 2 |
| Clinical Trial Progress | Phase 1 (2020-05-27) |
| Vendors | 41 |
Recent Clinical Trials for LY3214996
| Title | Sponsor | Phase |
|---|---|---|
| Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers | Lustgarten Foundation | Phase 1 |
| Combination Therapy of RMC-4630 and LY3214996 in Metastatic KRAS Mutant Cancers | The Netherlands Cancer Institute | Phase 1 |
| Study of LY3537982 in Cancer Patients With a Specific Genetic Mutation (KRAS G12C) | Loxo Oncology, Inc. | Phase 1 |
Clinical Trial Summary for LY3214996
Top disease conditions for LY3214996
Top clinical trial sponsors for LY3214996
US Patents for LY3214996
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| LY3214996 | ⤷ Sign Up | ERK inhibitors | Eli Lilly and Company (Indianapolis, IN) | ⤷ Sign Up |
| LY3214996 | ⤷ Sign Up | ERK inhibitors | Eli Lilly and Company (Indianapolis, IN) | ⤷ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for LY3214996
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| LY3214996 | Argentina | AR102977 | 2034-12-22 | ⤷ Sign Up |
| LY3214996 | Australia | AU2015369983 | 2034-12-22 | ⤷ Sign Up |
| LY3214996 | Brazil | BR112017011130 | 2034-12-22 | ⤷ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
